SARS transmission in Vietnam outside of the health-care setting

Epidemiology and Infection

Volumn 135, Issue 3, 2007, Pages 392-401

  Tuan, P A ^a   Horby, Peter ^b   Dinh, P N ^a   Mai, L T Q ^a   Zambon, M ^c   Shah, J ^d   Huy, V Q ^e   Bloom, S ^d   Gopal, R ^c   Comer, J ^d   Plant, A ^f  

^a NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Hanoi French Hospital   (Viet Nam)

^f CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; INFANT; INFECTION RISK; MALE; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SARS CORONAVIRUS; SERODIAGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; VIET NAM; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEVERE ACUTE RESPIRATORY SYNDROME; VIETNAM;

EID: 33947358975     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006996     Document Type: Article

References (41)

1. Anon. Severe Acute Respiratory Syndrome (SARS) - Multi-country outbreak - update 41, 28 April 2003, World Health Organization (http://www.who.int/csr/don/2003_04_28/en/). Accessed 11 October 2004.
2. Vu HT, et al. Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerging Infectious Diseases 2004; 10: 334-338.
3. Anon. Update: Outbreak of severe acute respiratory syndrome - worldwide, 2003. Morbidity and Mortality Weekly Report 2003; 52: 241-246, 248.
4. Lipsitch M, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300: 1966-1970.
5. Riley S, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 2003; 300: 1961-1966.
6. Wallinga J, Tennis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. American Journal of Epidemiology 2004; 160: 509-516.
7. Peck AJ, et al. Lack of SARS transmission and U.S. SARS case-patient. Emerging Infectious Diseases 2004; 10: 217-224.
8. Isakbaeva ET, et al. SARS-associated coronavirus transmission, United States. Emerging Infectious Diseases 2004; 10: 225-231.
9. Lee CC, et al. Seroprevalence of SARS coronavirus antibody in household contacts. Epidemiology and Infection 2005; 133: 1119-1122.
10. Xie SY, et al. Serological investigation on close contacts to patients with severe acute respiratory syndrome in an SARS outbreak. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 867-869.
11. Leung GM, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerging Infectious Diseases 2004; 10: 1653-1656.
12. Lau JT, et al. Probable secondary infections in households of SARS patients in Hong Kong. Emerging Infectious Diseases 2004; 10: 235-243.
13. Goh DL, et al. Secondary household transmission of SARS, Singapore. Emerging Infectious Diseases 2004; 10: 232-234.
14. Kuiken T, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362: 263-270.
15. Chan PK, et al. Immunofluorescence assay for serologic diagnosis of SARS. Emerging Infectious Diseases 2004; 10: 530-532.
16. Woo PC, et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004; 363: 841-845.
17. Wang Y, et al. Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases. Cell Molecular Immunology 2004; 1: 304-307.
18. Woo PC, et al. False-positive results in a recombinant severe acute respiratory syndrome-associated corona-virus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. Journal of Clinical Microbiology 2004; 42: 5885-5888.
19. Gao W, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003; 362: 1895-1896.
20. Bermingham A, et al. Laboratory diagnosis of SARS. Philosophical Transactions of the Royal Society of London, B: Biological Sciences 2004; 359: 1083-1089.
21. Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: A case series. Canadian Medical Association Journal 2003; 168: 1649-1660.
22. Anon. SARS outbreak in the Philippines. Weekly Epidemiological Record 2003; 78: 189-96. (http://www.who.int/wer/2003/en/wer7822.pdf).
23. Anon. Efficiency of Quarantine During an Epidemic of Severe Acute Respiratory Syndrome - Beijing, China, 2003. Morbidity and Mortality Weekly Report 2003; 52: 1037-1040.
24. Yu WC, et al. Prevalence of subclinical infection by the SARS coronavirus among general practitioners in Hong Kong. Scandinavian Journal of Infectious Diseases 2004; 36: 287-290.
25. Chan KH, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerging Infectious Diseases 2004; 10: 294-299.
26. Chu CM, et al. Initial viral load and the outcomes of SARS. Canadian Medical Association Journal 2004; 171: 1349-1352.
27. Yu IT, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. New England Journal of Medicine 2004; 350: 1731-1739.
28. Li HL, et al. Epidemiological investigation of nosocomial infection of SARS in medical staff of a hospital. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 355-358.
29. Lee HK, et al. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerging Infectious Diseases 2003; 9: 1491-1492.
30. Chang WT, et al. SARS exposure and emergency department workers. Emerging Infectious Diseases 2004; 10: 1117-1119.
31. Ho KY, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: Lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. Journal of Infectious Diseases 2004; 189: 642-647.
32. Li G, et al. Mild severe acute respiratory syndrome. Emerging Infectious Diseases 2003; 9: 1182-1183.
33. Ip M, et al. Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clinical Infectious Diseases 2004; 38: e116-118.
34. Yu F, et al. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology 2005; 12: 848-854.
35. Chan PK, et al. Severe acute respiratory syndrome-associated coronavirus infection. Emerging Infectious Diseases 2003; 9: 1453-1454.
36. Chen WQ, et al. Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China. Emerging Infectious Diseases 2005; 11: 89-94.
37. Wilder-Smith A, et al. Asymptomatic SARS corona-virus infection among healthcare workers, Singapore. Emerging Infectious Diseases 2005; 11: 1142-1145.
38. Dye C, Gay N. Epidemiology. Modeling the SARS epidemic. Science 2003; 300: 1884-1885.
39. Desenclos JC, et al. Introduction of SARS in France, March-April, 2003. Emerging Infectious Diseases 2004; 10: 195-200.
40. Nie Y, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated corona-virus infection. Journal of Infectious Diseases 2004; 190: 1119-1126.
41. Chen W, et al. Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. Journal of Medical Microbiology 2004; 53: 435-438.